Biopolym. Cell. 1999; 15(1):83-87.
http://dx.doi.org/10.7124/bc.00050A
Дискусії
Можливий універсальний механізм передачі сигналу до експресії α/β-інтерферонів, 2. Роль сАМР при індукції
1Карпов О. В.
  1. Інститут мікробіології і вірусології ім. Д. К. Заболотного НАН України
    вул. Академіка Заболотного, 154, Київ, Україна, 03680

Abstract

Проаналізовано літературні дані стосовно участі циклічного аденозин-3' ,5'-монофосфату (cAMP) при передачі сигналу до експресії α/β-інтерферонів (ІФН) у процесі індукції. Описано участь сАМР в активації протеїнкіназ, які беруть участь в індукції, а також ядерних факторів, що специфічно активу­ють регуляторні домени генів ІФН. Висунуто припущення, що сAMP виступає в ролі ключового вторинного месепджера, який опосередковує сигнал до індукції α/β-ІФН, початковим етапом якого є специфічна деформація клітинної мембрани під дією різних індукторів.
Повний текст: (PDF, англійською)

References

[1] Ho M. Induction and inducers of interferon. Interferon 1. General and applied aspects. Ed. A. Billiau. Amsterdam; New York; Oxford: Elsevier, 1984:79—124.
[2] Marcus P. I. Interferon induction by viruses: double-stranded ribonucleic acid as the common proximal inducer molecule Interferon 3. Mechanisms of production and action. Ed. R. M. Friedman. Amsterdam; New York; Oxford: Elsevier, 1984:113—175.
[3] Stringfellow DA. Induction of interferon with low molecular weight compounds: fluorenone esters, ethers (tilorone), and pyrimidinones. Methods Enzymol. 1981;78(Pt A):262-84.
[4] Torrence P. T., De Clercq E. Interferon induction by nucleic acids: structure-activity relationships. Interferon and their applications. Eds P. E. Came, W. A. Carter. Berlin: Springer, 1984:371—383.
[5] Maniatis T., Whittemore L. A., Du W. et al. Positive and negative control of human interferon-b gene expression Transcriptional regulation. Eds S. L. McKnight, K. R Yamamoto. New York: Cold Spring Harbor Lab. press, 1992:1193—1220.
[6] Taniguchi T. Regulation of cytokine gene expression. Annu Rev Immunol. 1988;6:439-64.
[7] Goodbourn S, Maniatis T. Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proc Natl Acad Sci USA. 1988;85(5):1447-51.
[8] Karpov AV. A possible general mechanism of the signal transfer switching on the a/b-interferons expression. 1. The local cell membrane deformation as the first induction stage. Biopolym. Cell. 1998; 14(6):561-566
[9] Buzhurina I. M., Panov M. A. Mechanisms of cellular response to external stimuli. Obshch. probl. fiz.-khim. biologii. M.: VINITI, 1986: 1—258
[10] Watson PA. Direct stimulation of adenylate cyclase by mechanical forces in S49 mouse lymphoma cells during hyposmotic swelling. J Biol Chem. 1990;265(12):6569-75.
[11] Olesen SP, Clapham DE, Davies PF. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature. 1988;331(6152):168-70.
[12] Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260(5111):1124-7.
[13] Preobrazhenskaia NP, Iurkevich AM. Current concepts concerning the role of cyclic-AMP as a regulator of enzyme activity. Vopr Med Khim. 1973;19(5):451-62.
[14] Sutherland EW.Studies on the mechanism of hormone action. Science. 1972;177(4047):401-8.
[15] Comb M, Birnberg NC, Seasholtz A, Herbert E, Goodman HM. A cyclic AMP- and phorbol ester-inducible DNA element. Nature. 1986;323(6086):353-6.
[16] Gonzalez GA1, Yamamoto KK, Fischer WH, Karr D, Menzel P, Biggs W 3rd, Vale WW, Montminy MR. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature. 1989;337(6209):749-52.
[17] Meldolesi MF, Friedman RM, Kohn LD. An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state. Biochem Biophys Res Commun. 1977;79(1):239-46.
[18] Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science. 1984;225(4668):1365-70.
[19] Thacore HR, Lin HY, Davis PJ, Schoenl M. Effect of protein kinase C inhibitors on interferon-beta production by viral and non-viral inducers. J Gen Virol. 1990;71 ( Pt 12):2833-9.
[20] Marcus PI, Sekellick MJ. Interferon induction by viruses. XVI. 2-Aminopurine blocks selectively and reversibly an early stage in interferon induction. J Gen Virol. 1988;69 ( Pt 7):1637-45.
[21] Zinn K, Keller A, Whittemore LA, Maniatis T. 2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science. 1988;240(4849):210-3.
[22] Cambier JC, Newell MK, Justement LB, McGuire JC, Leach KL, Chen ZZ. Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature. 1987;327(6123):629-32.
[23] Cachelin AB, de Peyer JE, Kokubun S, Reuter H. Ca2+ channel modulation by 8-bromocyclic AMP in cultured heart cells. Nature. 1983;304(5925):462-4.
[24] Katada T, Gilman AG, Watanabe Y, Bauer S, Jakobs KH. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem. 1985;151(2):431-7.
[25] Romanchikov YuM. Growth factors, oncogenes, and second messengers. Usp Sovrem Biol. 1991; 111(1):19-33.
[26] Corbin JD, Beebe SJ, Blackmore PF. cAMP-dependent protein kinase activation lowers hepatocyte cAMP. J Biol Chem. 1985;260(15):8731-5.
[27] Hai TW, Liu F, Allegretto EA, Karin M, Green MR. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1 Genes Dev. 1988;2(10):1216-26.
[28] Hai TW, Liu F, Coukos WJ, Green MR. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 1989;3(12B):2083-90.
[29] Du W, Maniatis T. An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected] Proc Natl Acad Sci U S A. 1992;89(6):2150-4.
[30] Liu F, Green MR. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell. 1990;61(7):1217-24.
[31] Hiscott J, Alper D, Cohen L, Leblanc JF, Sportza L, Wong A, Xanthoudakis S. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer. J Virol. 1989;63(6):2557-66.
[32] Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705-16.
[33] Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47(6):921-8.
[34] Baeuerle PA, Baltimore D. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev. 1989;3(11):1689-98.
[35] Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 1990;344(6267):678-82.
[36] Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol. 1989;9(6):2424-30.
[37] Lenardo MJ, Fan CM, Maniatis T, Baltimore D. The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell. 1989;57(2):287-94.
[38] Visvanathan KV, Goodbourn S. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J. 1989;8(4):1129-38.
[39] Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature. 1989;337(6204):270-2.
[40] Galetyan G. G., Mkhitaryan F. S., Gasparyan N. T. Effect of dsRNA on the content of cyclic nucleotides in various tissues of eukaryotes. Zhurn. eksperim. i klin. meditsiny. 1989. 29, N 5:477—482.
[41] Zemskov VM. Synthetic polynucleotides as nonspecific stimulators of the body's immunological system. Usp Sovrem Biol. 1973;76(4):3-20.
[42] Wathelet MG, Berr PM, Huez GA. Regulation of gene expression by cytokines and virus in human cells lacking the type-I interferon locus. Eur J Biochem. 1992;206(3):901-10.
[43] Winchurch R, Ishizuka M, Webb D, Braun W. Adenyl cyclase activity of spleen cells exposed to immunoenhancing synthetic oligo- and polynucleotides. J Immunol. 1971;106(5):1399-400.
[44] Braun W, Ishizuka M. Cyclic AMP and immune responses. II. Phosphodiesterase inhibitors as potentiators of polynucleotide effects on antibody formation. J Immunol. 1971;107(4):1036-42.
[45] Butcher RW, Sutherland EW. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962;237:1244-50.
[46] Triner L, Vulliemoz Y, Schwartz I, Nahas GG. Cyclic phosphodiesterase activity and the action of papaverine. Biochem Biophys Res Commun. 1970;40(1):64-9.
[47] Grigorian SS, Poverennyi AM, Ershov FI. Vasodilators as interferon inducers. Vopr Virusol. 1987;32(2):204-8.